Metabolic study to improve insulin sensitivity in type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests a new medication to see if it can improve how your body responds to insulin and boost your cells' energy (mitochondrial function). It is for adults with type 1 diabetes who are already on insulin and have good overall health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 69 years old and have had type 1 diabetes for at least 1 year.
- You take insulin every day (by injections or pump).
- Your blood sugar control (HbA1c) is below 9.5%.
- Your body mass index (BMI) is between 18.5 and 40.
- You have no recent heart problems, pancreatitis, or severe low blood sugar (needing help) in the last 3 months.
- You are not taking certain diabetes medications (other than insulin) or blood thinners.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an oral medication that may help your body respond better to insulin. It's for people with type 1 diabetes who use an automated insulin pump and are willing to take a daily pill for 12 weeks.
This early-stage study tests a new investigational medication in three groups: healthy adults with normal weight, adults who are overweight or obese, and men with type 1 diabetes who are also overweight. The research aims to understand how safe the medication is and how the body processes it.
This study tests if adding a non-insulin medication can lower the amount of insulin needed while improving heart and metabolic health in people with type 1 diabetes. It may also help understand how this approach works in people with a genetic form of diabetes (GCK-MODY).
This study offers a structured education course and regular checkups to help adults with type 1 diabetes better manage their blood sugar and overall health. Participants will learn about their condition and receive support to improve metabolic indicators.
This study tests a new medication, MTX228, to see if it can help people with type 1 diabetes who still make some insulin. It may slow the loss of your own insulin production and improve blood sugar control.
This study tests whether high-intensity interval training can improve how your body uses insulin. It is for people with type 2 diabetes who are not on insulin and have had diabetes for 1 to 5 years.
Hear when a new Glucose Metabolism Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.